|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 非诺贝特治疗与2型糖尿病患者长期心血管病风险的关系显示文摘2型糖尿病患者心血管病风险高,部分原因在于高三酰甘油和低高密度脂蛋白胆固醇血症。而在他汀类药物治疗基础上,加强降低三酰甘油治疗,能否降低这种风险尚不清楚。该研究的目的是在使用他汀类药物治疗的2型糖尿病患者中,确定非诺贝特能否降低心血管病风险。 | 刘莉 叶鹏 Elam MB Ginsberg HN Lovato LC Corson M Largay J Leiter LA Lopez C O'Connor PJ Sweeney ME Weiss D Friedewald WT Buse JB Gerstein HC Probstfield J Grimm R Ismail-Beigi F Goff DC Jr Fleg JL Rosenberg Y Byington RP ACCORDION study investigators | 2017 | 中华高血压杂志2017，25，6： | 7 |
| 2 | 万维链:区块链跨链技术及应用生态显示文摘我们的核心团队进入区块链比较早,在2014年就做了全球知名的区块链项目——公证通。我们经常在想怎样把区块链应用到实体经济中,发现“区块经济”是一个方向。我们到过浙江中部地区做调研,浙江很多地方都是带状经济,也就是“区块经济”,各个区块个体之间、企业之间需要建立一个机制,就是联盟链。 | 吕旭军 Dustin Byington | 2018 | 杭州2018，，18： | 4 |
| 3 | Mobile Agent and Security显示文摘 | Greenberg M S Byington L C Harper D G | 1998 | IEEE Communication Magazine1998，36，7： | 2 |
| 4 | Effects of intensive glucose lowering in type 2 diabetes显示文摘 | Gerstein HC Miller ME Byington RP | 2008 | N Engl J Med2008，358，24： | 1 |
| 5 | Effects of intensive blood-pressure control in type 2 diabetes mellitus显示文摘 | Cushman WC Evans GW Byington RP | | 0，，17： | 1 |
| 6 | Effects of intensive glucose lowering in type 2 diabetes 显示文摘 | Gerstein HC Miller ME Byington RP | 2008 | N Engl J Med2008，358，24： | 1 |
| 7 | Pravastain lipida, and atherosclerosis the carotid arteries (PLAC Ⅱ) 显示文摘 | Furberg C D Byington R P Crouse J R | 1995 | Am J Cardiol1995，75，7： | 1 |
| 8 | Effects of intensive blood-pressure control in type 2 diabetes mellitus显示文摘 | Cushman W C Evans G W Byington R P | 2010 | N Engl J Med2010，362，17： | 1 |
| 9 | Pravastatin, lipids, and atherosclerosis in the carotid arteries(PLAC-II)显示文摘 | Crouse JR Byington RP Bond MG | 1995 | The Am J of Cardiol1995，75，3： | 1 |
| 10 | Effect of amlodipine on the pregression of atherosclerosis and the occurrence of clinical events显示文摘 | Pitt B Byington RP Fruberg CD | 2002 | Circulation2002，102，13： | 1 |
| 11 | Effeet of amlodipine on the progression of atheroselerosis and the occurrence of clinical events PREVENT Investigators 显示文摘 | Pitt B Byington RP Furberg CD | 2000 | Clireulation2000，102，13： | 1 |
| 12 | The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America显示文摘 | Bradley JS Byington CL Shah SS | 2011 | Clin Infect Dis2011，53，7： | 1 |
| 13 | Executive summary:the management of community-acquired pneumonia in infants and children older than 3 months of age:clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America显示文摘 | Bradley JS Byington CL Shah SS | | 0，，07： | 1 |
| 14 | Effects of intensive glucose lowering in type 2 diabetes 显示文摘 | Gerstein HC Miller ME Byington RP | 2008 | N Engl J Med2008，，358： | 1 |
| 15 | Reductase inhibitor monotherapy and stroke prevention显示文摘 | Crouse JR Byington RP Hoen HM | 1997 | Arch Intern Med1997，157，7： | 1 |
| 16 | Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events显示文摘 | Pitt B Byington RP Furberg CD | 2000 | Circulation2000，102，13： | 1 |
| 17 | Efrect of amlodipine on the progression of atherosclerosis and the occurrenee of elinical events 显示文摘 | Pitt B Byington RP | 2000 | Cir- culation2000，102，13： | 1 |
| 18 | Pravastatin, lipids and atherosclerosis in carotid arteries (PLAC-1I ) 显示文摘 | Crouse JR Byington RP Bond MG | 1995 | Am J Cardiol1995，75，7： | 1 |
| 19 | Outcome results of the fosinopril versus amlodipine cardiovascular events randomized trial(FACET)in patients with hypertension and NIDDM显示文摘 | Tatti P Pahor M Byington RP | 1998 | Diabetes Care1998，21，： | 1 |
| 20 | Action to con- trol cardiovascular risk in diabetes (ACCORD) trial : design and methods 显示文摘 | BUSE J B BIGGER J T BYINGTON R P | 2007 | Am J Cardiol2007，99，12： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员